Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded site revision tag Revision: v3.4.2. Removed the prior government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check46 days agoChange DetectedA site-wide maintenance notice about funding and the NIH Clinical Center's operating status is displayed, and the page revision has been updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check67 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. This appears to be a minor update to the page version with no changes to study details or availability.SummaryDifference0.0%

Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.